Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug repurposing against SARS-CoV-2 using computational approaches
Sumit Kumar, Svitlana Kovalenko, Shakshi Bhardwaj, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 7, pp. 2015-2027
Open Access | Times Cited: 24

Showing 24 citing articles:

Drug repurposing: An effective strategy to accelerate contemporary drug discovery
Peng Zhan, Bin Yu, Liang Ouyang
Drug Discovery Today (2022) Vol. 27, Iss. 7, pp. 1785-1788
Open Access | Times Cited: 40
Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2
Adel S. Girgis, Siva S. Panda, Benson M. Kariuki, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6603-6603
Open Access | Times Cited: 12
Ramipril, perindopril and trandolapril as potential chemosensitizers in ovarian cancer: considerations for drug repurposing
Katarzyna Regulska, Paulina Gieremek, Marcin Michalak, et al.
Drug Discovery Today (2025), pp. 104331-104331
Closed Access
Repurposing of nervous system drugs for cancer treatment: recent advances, challenges, and future perspectives
Zixun Wang, Xu Chen, Qi Wang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Identification of lurasidone as a potent inhibitor of severe fever with thrombocytopenia syndrome virus by targeting the viral nucleoprotein
Ting Cheng, Qingcui Xiao, Jing Cui, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Modern Computational Intelligence Based Drug Repurposing for Cancer
Roja Rani Budha, Nikhat Khan, Saba Khan, et al.
(2025), pp. 859-884
Closed Access
Computational repurposing of drugs for viral diseases and current and future pandemics
David A. Winkler
Journal of Mathematical Chemistry (2024) Vol. 62, Iss. 10, pp. 2844-2879
Open Access | Times Cited: 3
Repurposing of antimycobacterium drugs for COVID-19 treatment by targeting SARS CoV-2 main protease: An in-silico perspective
Ayon Chakraborty, Rajesh Ghosh, Saswati Soumya Mohapatra, et al.
Gene (2024) Vol. 922, pp. 148553-148553
Closed Access | Times Cited: 3
Recent updates on the biological efficacy of approved drugs and potent synthetic compounds against SARS-CoV-2
Anjani Anjani, Sumit Kumar, Brijesh Rathi, et al.
RSC Advances (2023) Vol. 13, Iss. 6, pp. 3677-3687
Open Access | Times Cited: 8
Ganoderma microsporum immunomodulatory protein acts as a multifunctional broad-spectrum antiviral against SARS-CoV-2 by interfering virus binding to the host cells and spike-mediated cell fusion
Ha Phan Thanh Ho, Di Ngoc Kha Vo, Tung‐Yi Lin, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113766-113766
Open Access | Times Cited: 11
Indole-based compounds as potential drug candidates for SARS-CoV-2
Adel S. Girgis, Siva S. Panda, Benson M. Kariuki, et al.
(2023)
Open Access | Times Cited: 6
Pharmaceutical Prospects of Curcuminoids for the Remedy of COVID-19: Truth or Myth
Yaw‐Syan Fu, Wan‐Yi Ho, Ning Kang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
Drug Repurposing - Advances, Scopes and Opportunities in Drug Discovery
Mithun Rudrapal
IntechOpen eBooks (2022)
Open Access | Times Cited: 9
Design of Novel Enantiopure Dispirooxindolopyrrolidine-Piperidones as Promising Candidates toward COVID-19: Asymmetric Synthesis, Crystal Structure and In Silico Studies
Amani Toumi, Sarra Boudriga, Yasmine M. Mandour, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3945-3945
Open Access | Times Cited: 8
Recent advances in computational drug discovery for therapy against coronavirus SARS-CoV-2
Vladimir V. Ivanov, Kateryna Lohachova, Yaroslav V. Kolesnik, et al.
ScienceRise Pharmaceutical Science (2023), Iss. 6(46)
Open Access | Times Cited: 4
Computational Approaches to Designing Antiviral Drugs against COVID-19: A Comprehensive Review
Mohan Singh, Nidhi Singh, Divya Mishra, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 33, pp. 2601-2617
Closed Access | Times Cited: 4
In Silico Therapeutic Study: The Next Frontier in the Fight against SARS-CoV-2 and Its Variants
Calvin R. Wei, Zarrin Basharat, Godwin C. Lang’at
Drugs and Drug Candidates (2024) Vol. 3, Iss. 1, pp. 54-69
Open Access | Times Cited: 1
Discovery of druggable potent inhibitors of serine proteases and farnesoid X receptor by ligand-based virtual screening to obstruct SARS-CoV-2
Sumera Zaib, Nehal Rana, Hafiz Saqib Ali, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127379-127379
Closed Access | Times Cited: 3
Dynamics and binding affinity of nucleoside and non-nucleoside inhibitors with RdRp of SARS-CoV-2: a molecular screening, docking, and molecular dynamics simulation study
Archana Chinnamadhu, Jaganathan Ramakrishnan, Suganya Suresh, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 20, pp. 10396-10410
Closed Access | Times Cited: 4
SARS-CoV-2 Omicron Variant in Medicinal Chemistry Research
Weslany Souza Rocha, Peng Zhan, Edeildo Ferreira da Silva‐Júnior
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 17, pp. 1625-1639
Closed Access | Times Cited: 1
Computational Approaches in Drug Repurposing
Christabel Chikodi Ekeomodi, Kingsley Ifeanyi Obetta, Mmesoma Linus Okolocha, et al.
IntechOpen eBooks (2023)
Open Access | Times Cited: 1
Targeting RdRp of SARS-CoV-2 with De Novo Molecule Generation
Amal Vijay, Venkata Sai Sreyas Adury, Arnab Mukherjee
ACS Applied Bio Materials (2023) Vol. 7, Iss. 2, pp. 609-616
Open Access | Times Cited: 1
In Silico Methods Used in Drug Repurposing
Neelanjan Chowdhury, N. Satheeshkumar
Drug repurposing (2024), pp. 29-41
Closed Access
Pharmacotherapeutic Treatment Strategies COVID-19: Lessons Learned and Perspectives
Abdurashid Khamidovich Ashirmetov
Exploratory Research and Hypothesis in Medicine (2022) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 2
Small molecules in the race of COVID-19 drug development
Rajiv Jash, DSNBK Prasanth, Moumita Jash, et al.
Journal of Asian Natural Products Research (2023) Vol. 25, Iss. 12, pp. 1133-1154
Closed Access
Page 1

Scroll to top